Biotech · Private company
NovoCure Ltd.
Track this companyFree. Adds NovoCure Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials2512 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- GemcitabinePhase 3 · Pancreas AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Immune checkpoint inhibitors or docetaxelPhase 3 · Nonsmall Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- nab paclitaxelPhase 3 · Pancreas AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NovoTTF-200M devicePhase 3 · Brain Metastases From Non-small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
- NovoTTF-200TPhase 3 · Pancreas AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NovoTTF-200TPhase 3 · Metastatic Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- NovoTTF-200TPhase 3 · Nonsmall Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Optune® devicePhase 3 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 3 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 3 · Metastatic Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Platinum based chemotherapyPhase 3 · Metastatic Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 3 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Optune®Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Pre-operative Tumor Treating Fields in Patients With Resectable Lung CancerNA · WITHDRAWN · started Oct 1, 2026ClinicalTrials.gov NCT06552000 · fetched Nov 12, 2026
- NovoTTF-200A + Pembrolizumab In Melanoma Brain MetastasisPHASE1_PHASE2 · WITHDRAWN · started Oct 30, 2025ClinicalTrials.gov NCT04129515 · fetched Nov 12, 2026
- A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal MetastasisPHASE1 · RECRUITING · started Aug 18, 2025ClinicalTrials.gov NCT06906900 · fetched Nov 12, 2026
- EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed GlioblastomaPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 3, 2025ClinicalTrials.gov NCT06556563 · fetched Nov 12, 2026
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCPHASE3 · RECRUITING · started Jul 31, 2024ClinicalTrials.gov NCT06216301 · fetched Nov 12, 2026
- A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic AdenocarcinomaPHASE2 · RECRUITING · started Jul 1, 2024ClinicalTrials.gov NCT05624918 · fetched Nov 12, 2026
- Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas CancerNA · RECRUITING · started Sep 21, 2023ClinicalTrials.gov NCT05679674 · fetched Nov 12, 2026
- A Study of Tumor-Treating Fields (TTFields) in People With Lung AdenocarcinomaPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 4, 2023ClinicalTrials.gov NCT05764954 · fetched Nov 12, 2026
- WBSI Guided Personalized Delivery of TTFieldsNA · RECRUITING · started Jan 15, 2023ClinicalTrials.gov NCT05086497 · fetched Nov 12, 2026
- Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain MetastasesPHASE1 · TERMINATED · started Oct 13, 2022ClinicalTrials.gov NCT05341349 · fetched Nov 12, 2026
- Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PACPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Apr 25, 2022ClinicalTrials.gov NCT04605913 · fetched Nov 12, 2026
- Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal MelanomaPHASE1 · COMPLETED · started Feb 28, 2022ClinicalTrials.gov NCT05004025 · fetched Nov 12, 2026
- Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed GlioblastomaPHASE1 · COMPLETED · started May 21, 2021ClinicalTrials.gov NCT04474353 · fetched Nov 12, 2026
- Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBMNA · COMPLETED · started Dec 8, 2020ClinicalTrials.gov NCT04471844 · fetched Nov 12, 2026
- Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant AstrocytomaNA · COMPLETED · started May 21, 2020ClinicalTrials.gov NCT03450850 · fetched Nov 12, 2026
- Niraparib/TTFields in GBMPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 30, 2019ClinicalTrials.gov NCT04221503 · fetched Nov 12, 2026
- Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)PHASE3 · COMPLETED · started May 10, 2018ClinicalTrials.gov NCT03377491 · fetched Nov 12, 2026
- Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With GlioblastomaEARLY_PHASE1 · COMPLETED · started May 4, 2018ClinicalTrials.gov NCT03477110 · fetched Nov 12, 2026
- Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat GlioblastomaPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 1, 2018ClinicalTrials.gov NCT03223103 · fetched Nov 12, 2026
- Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 23, 2018ClinicalTrials.gov NCT03405792 · fetched Nov 12, 2026
- HUMC 1612: Optune NovoTTF-200A SystemPHASE1 · COMPLETED · started Apr 6, 2017ClinicalTrials.gov NCT03128047 · fetched Nov 12, 2026
- Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)PHASE3 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT02973789 · fetched Nov 12, 2026
- Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 MeningiomaPHASE2 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02847559 · fetched Nov 12, 2026
- Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).PHASE3 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02831959 · fetched Nov 12, 2026
- Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic MeningiomaNA · ACTIVE_NOT_RECRUITING · started Jun 1, 2013ClinicalTrials.gov NCT01892397 · fetched Nov 12, 2026